Prophylactic drug management of migraine

被引:0
|
作者
Göbel, H [1 ]
Heinze, A [1 ]
机构
[1] Univ Kiel, Neurol Verhaltensmed Schmerzklin Kiel, D-24149 Kiel, Germany
来源
NERVENARZT | 2003年 / 74卷 / 10期
关键词
migraine prophylaxis; indication; rules; mistakes; substances; stratified care;
D O I
10.1007/s00115-003-1616-0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Migraine prophylaxis with drugs is still an essential part of migraine therapy. This is especially true for those patients with frequent migraines who are in danger of developing drug-induced headaches. Migraine Prophylaxis should be taken in consideration in patients who suffer from 7 or more migraine days per month in spite of all non-pharmacological efforts. When choosing a prophylactic drug not only efficacy but tolerability and safety for long-term intake should be considered. Prophylactic drugs used to be classified as drugs of first, second and third choice. According to this step care model treatment was started with a drug of first choice and only in case of lack of efficacy or adverse events a drug of lower choice was selected. Today, in contrast to the traditional step care a stratified care is favored. Treatment is individualized based on an assessment of the patients' medical needs, on comorbidity, the migraine phenotype and most important the individual situation of the patient in life. The paper gives an overview of the efficacy and tolerability of drugs used in migraine prophylaxis.
引用
收藏
页码:915 / 932
页数:18
相关论文
共 50 条
  • [1] Prophylactic drug management of migraine
    Göbel, H
    Heinze, A
    [J]. SCHMERZ, 2002, 16 (03): : 223 - 240
  • [2] Prophylactic management of migraine
    Mannix, LK
    [J]. HEADACHE QUARTERLY-CURRENT TREATMENT AND RESEARCH, 2000, 11 (03): : 179 - 180
  • [3] Prophylactic drug treatment of migraine
    Massiou, H
    Bousser, MG
    [J]. REVUE NEUROLOGIQUE, 2005, 161 (6-7) : 681 - 684
  • [4] An audit of prophylactic drug prescribing in migraine
    Ford, S.
    Tyagi, A.
    McKenzie, M.
    [J]. CEPHALALGIA, 2006, 26 (11) : 1370 - 1370
  • [5] PROPHYLACTIC DRUG-TREATMENT OF MIGRAINE
    MASSIOU, H
    BOUSSER, MG
    [J]. NEW TRENDS IN CLINICAL NEUROPHARMACOLOGY: CALCIUM ANATONISTS, ACUTE NEUROLOGY, HEADACHE AND MOVEMENT DISORDERS, 1988, 7 : 156 - 162
  • [6] The Influence of Migraine Prophylactic Drug on Hyperleptinemia as a Risk of Chronic Migraine
    Kitamura, E.
    Hamada, J.
    Kanazawa, N.
    Hamada, Y.
    Masuda, R.
    Nishiyama, K.
    [J]. CEPHALALGIA, 2013, 33 (S8) : 255 - 256
  • [7] METHODOLOGICAL ASPECTS OF PROPHYLACTIC DRUG TRIALS IN MIGRAINE
    OLESEN, J
    KRABBE, AA
    TFELTHANSEN, P
    [J]. CEPHALALGIA, 1981, 1 (03) : 127 - 141
  • [8] Drug safety and tolerability in prophylactic migraine treatment
    Vecsei, Laszlo
    Majlath, Zsofia
    Szok, Delia
    Csati, Anett
    Tajti, Janos
    [J]. EXPERT OPINION ON DRUG SAFETY, 2015, 14 (05) : 667 - 681
  • [9] Evidence based migraine prophylactic drug therapy
    Becker, WJ
    [J]. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1999, 26 : S27 - S32
  • [10] Investigation of Prophylactic Drug Use Adherence in Patients with Migraine
    Can, Ezgi
    Tunc, Tugba
    [J]. GAZI MEDICAL JOURNAL, 2024, 35 (02): : 179 - 185